|
1
|
Xiang D, Xie L, Xu Y, Li Z, Hong Y and
Wang P: Papillary thyroid microcarcinomas located at the middle
part of the middle third of the thyroid gland correlates with the
presence of neck metastasis. Surgery. 157:526–533. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kim HY, Park WY, Lee KE, Park WS, Chung
YS, Cho SJ and Youn YK: Comparative analysis of gene expression
profiles of papillary thyroid microcarcinoma and papillary thyroid
carcinoma. J Cancer Res Ther. 6:452–457. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hughes DT, Haymart MR, Miller BS, Gauger
PG and Doherty GM: The most commonly occurring papillary thyroid
cancer in the United States is now a microcarcinoma in a patient
older than 45 years. Thyroid. 21:231–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chou CK, Yang KD, Chou FF, Huang CC, Lan
YW, Lee YF, Kang HY and Liu RT: Prognostic implications of miR-146b
expression and its functional role in papillary thyroid carcinoma.
J Clin Endocrinol Metab. 98:E196–E205. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee JC, Zhao JT, Clifton-Bligh RJ, Gill A,
Gundara JS, Ip JC, Glover A, Sywak MS, Delbridge LW, Robinson BG
and Sidhu SB: MicroRNA-222 and microRNA-146b are tissue and
circulating biomarkers of recurrent papillary thyroid cancer.
Cancer. 119:4358–4365. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lang BH, Tang AH, Wong KP, Shek TW, Wan KY
and Lo CY: Significance of size of lymph node metastasis on
postsurgical stimulated thyroglobulin levels after prophylactic
unilateral central neck dissection in papillary thyroid carcinoma.
Ann Surg Oncol. 19:3472–3478. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chruścik A and Lam AK: Clinical
pathological impacts of microRNAs in papillary thyroid carcinoma: A
crucial review. Exp Mol Pathol. 99:393–398. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liang J, Cai W, Feng D, Teng H, Mao F,
Jiang Y, Hu S, Li X, Zhang Y, Liu B and Sun ZS: Genetic landscape
of papillary thyroid carcinoma in the Chinese population. J Pathol.
244:215–226. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hale BJ, Yang CX and Ross JW: Small RNA
regulation of reproductive function. Mol Reprod Dev. 81:148–159.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chi SW, Zang JB, Mele A and Darnell RB:
Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature.
460:479–486. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang XZ, Hang YK, Liu JB, Hou YQ, Wang N
and Wang MJ: Over-expression of microRNA-375 inhibits papillary
thyroid carcinoma cell proliferation and induces cell apoptosis by
targeting ERBB2. J Pharmacol Sci. 130:78–84. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Borrelli N, Denaro M, Ugolini C, Poma AM,
Miccoli M, Vitti P, Miccoli P and Basolo F: miRNA expression
profiling of ‘noninvasive follicular thyroid neoplasms with
papillary-like nuclear features’ compared with adenomas and
infiltrative follicular variants of papillary thyroid carcinomas.
Mod Pathol. 30:39–51. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ma X, Wei J, Zhang L, Deng D, Liu L, Mei
X, He X and Tian J: miR-486-5p inhibits cell growth of papillary
thyroid carcinoma by targeting fibrillin-1. Biomed Pharmacother.
80:220–226. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu L, Wang J, Li X, Ma J, Shi C, Zhu H,
Xi Q, Zhang J, Zhao X and Gu M: miR-204-5p suppresses cell
proliferation by inhibiting IGFBP5 in papillary thyroid carcinoma.
Biochem Biophys Res Commun. 457:621–626. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vasilatou D, Papageorgiou S, Pappa V,
Papageorgiou E and Dervenoulas J: The role of microRNAs in normal
and malignant hematopoiesis. Eur J Haematol. 84:1–16. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
He Y, Jiang X and Chen J: The role of
miR-150 in normal and malignant hematopoiesis. Oncogene.
33:3887–3893. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang F, Ren X and Zhang X: Role of
microRNA-150 in solid tumors. Oncol Lett. 10:11–16. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Srivastava SK, Bhardwaj A, Singh S, Arora
S, Wang B, Grizzle WE and Singh AP: MicroRNA-150 directly targets
MUC4 and suppresses growth and malignant behavior of pancreatic
cancer cells. Carcinogenesis. 32:1832–1839. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu Q, Jin H, Yang Z, Luo G, Lu Y, Li K,
Ren G, Su T, Pan Y, Feng B, et al: miR-150 promotes gastric cancer
proliferation by negatively regulating the pro-apoptotic gene EGR2.
Biochem Biophys Res Commun. 392:340–345. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang L, Xi Y, Sun C, Zhang F, Jiang H, He
Q and Li D: CDK3 is a major target of miR-150 in cell proliferation
and anti-cancer effect. Exp Mol Pathol. 102:181–190. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou D, Li Z and Bai X: BRAFV600E and
RET/PTC promote proliferation and migration of papillary thyroid
carcinoma cells in vitro by regulating nuclear factor-κB. Med Sci
Monit. 23:5321–5329. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Talmadge JE and Fidler IJ: AACR centennial
series: The biology of cancer metastasis: Historical perspective.
Cancer Res. 70:5649–5669. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Saiselet M, Gacquer D, Spinette A, Craciun
L, Decaussin-Petrucci M, Andry G, Detours V and Maenhaut C: New
global analysis of the microRNA transcriptome of primary tumors and
lymph node metastases of papillary thyroid cancer. BMC Genomics.
16:8282015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qiu Z, Li H, Wang J and Sun C: miR-146a
and miR-146b in the diagnosis and prognosis of papillary thyroid
carcinoma. Oncol Rep. 38:2735–2740. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kolanowska M, Wójcicka A, Kubiak A,
Świerniak M, Kotlarek M, Maciąg M, Gaj P, Koperski Ł, Górnicka B
and Jażdżewski K: Functional analysis of a novel,
thyroglobulin-embedded microRNA gene deregulated in papillary
thyroid carcinoma. Sci Rep. 7:99422017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li J, Hu L, Tian C, Lu F, Wu J and Liu L:
microRNA-150 promotes cervical cancer cell growth and survival by
targeting FOXO4. BMC Mol Biol. 16:242015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang S, Chen Y, Wu W, Ouyang N, Chen J,
Li H, Liu X, Su F, Lin L and Yao Y: miR-150 promotes human breast
cancer growth and malignant behavior by targeting the pro-apoptotic
purinergic P2X7 receptor. PLoS One. 8:e807072013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cao M, Hou D, Liang H, Gong F, Wang Y, Yan
X, Jiang X, Wang C, Zhang J, Zen K, et al: miR-150 promotes the
proliferation and migration of lung cancer cells by targeting SRC
kinase signalling inhibitor 1. Eur J Cancer. 50:1013–1024. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gautam SK, Kumar S, Cannon A, Hall B,
Bhatia R, Nasser MW, Mahapatra S, Batra SK and Jain M: MUC4 mucin-a
therapeutic target for pancreatic ductal adenocarcinoma. Expert
Opin Ther Targets. 21:657–669. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Singh AP, Moniaux N, Chauhan SC, Meza JL
and Batra SK: Inhibition of MUC4 expression suppresses pancreatic
tumor cell growth and metastasis. Cancer Res. 64:622–630. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nam KH, Noh TW, Chung SH, Lee SH, Lee MK,
Hong SW, Chung WY, Lee EJ and Park CS: Expression of the membrane
mucins MUC4 and MUC15, potential markers of malignancy and
prognosis, in papillary thyroid carcinoma. Thyroid. 21:745–750.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Valderrama-Treviño I A, Barrera-Mera B,
Ceballos-Villalva C J and Montalvo-Javé E E: Hepatic metastasis
from colorectal cancer. Euroasian J Hepatogastroenterol. 7:166–175.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sun J, Luo Q, Liu L, Yang X, Zhu S and
Song G: Salinomycin attenuates liver cancer stem cell motility by
enhancing cell stiffness and increasing F-actin formation via the
FAK-ERK1/2 signalling pathway. Toxicology. 384:1–10. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhao X and Guan JL: Focal adhesion kinase
and its signaling pathways in cell migration and angiogenesis. Adv
Drug Deliv Rev. 63:610–615. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang J and Hochwald SN: The role of FAK
in tumor metabolism and therapy. Pharmacol Ther. 142:154–163. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mendoza MC, Vilela M, Juarez JE, Blenis J
and Danuser G: ERK reinforces actin polymerization to power
persistent edge protrusion during motility. Sci Signal. 8:ra472015.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Natarajan M, Hecker TP and Gladson CL: FAK
signaling in anaplastic astrocytoma and glioblastoma tumors. Cancer
J. 9:126–133. 2003. View Article : Google Scholar : PubMed/NCBI
|
